Grace Therapeutics (GRCE) Interest & Investment Income (2019 - 2026)
Grace Therapeutics (GRCE) posted Interest & Investment Income of $141,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 31.2% from $205,000 a year earlier but up 2.2% from the prior quarter.
Grace Therapeutics (GRCE) Interest & Investment Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Grace Therapeutics was $621,000, down 8.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $685,000, down 3.7% from FY2025.
- Annual Interest & Investment Income shows a three-year compound annual growth rate of 40.7% (FY2023 to FY2026).
- In prior fiscal years, Grace Therapeutics' Interest & Investment Income was $711,000 in FY2025 (-22.0%), $911,000 in FY2024 (+270.3%) and $246,000 in FY2023.
- Quarterly Interest & Investment Income has run from a low of $14,000 in fiscal Q2 2022 to a high of $316,000 in fiscal Q3 2024 over five years.
- On a year-over-year basis, Interest & Investment Income increased in 1 of the last eight quarters, with an average decline of 18.3%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q2 2024, with growth of 488.9%; the weakest was fiscal Q3 2025, with a decline of 56.3%.
- According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $138,000 (Q4 2026), $170,000 (Q3 2026) and $172,000 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Grace Therapeutics | 33.69 Mn | 33.69 Mn | - | 141,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 172,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 249,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 134,000.00 |
| Mar 31, 2023 | 112,000.00 |
| Dec 31, 2022 | 67,000.00 |
| Sep 30, 2022 | 36,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 20,000.00 |
Grace Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();